Bilobil intense capsules

País: Armenia

Idioma: inglés

Fuente: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingredientes activos:

ginkgo biloba folies dry extract

Disponible desde:

KRKA d.d.

Código ATC:

N06DX02

Designación común internacional (DCI):

ginkgo biloba folies dry extract

Dosis:

120mg

formulario farmacéutico:

capsules

Unidades en paquete:

(20/2x10/) in blister

tipo de receta:

OTC

Estado de Autorización:

Registered

Fecha de autorización:

2023-03-10

Ficha técnica

Summary of Product Characteristics
CONFIDENTIAL
Bilobil capsules 120 mg
VOL: 1; P: 10 / 33
PI_Text037101_1
– Updated:
Page 1 of 6
1.
NAME OF THE MEDICINAL PRODUCT
Bilobil intense 120 mg capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each hard capsule contains 120 mg of extract (as dry extract, refined
and quantified) from _Ginkgo _
_biloba_ L_., _folium (Ginkgo leaf) (35
–
67:1), corresponding to:
-
26.4 to 32.4 mg of flavonoids expressed as flavone glycosides,
-
3.36 to 4.08 mg of ginkgolides A, B, C and
-
3.12 to 3.84 mg of bilobalide.
Excipients: lactose (188.1 mg), glucose (6 mg).
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Capsule.
The capsules are brown. They contain a light to dark brown powder with
visible darker particles and
possible small clods.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Bilobil intense capsules are a herbal medicinal product that is
recommended for symptomatic
treatment:
-
in disturbances of cerebral circulation and function (syndrome of
dementia in primary
degenerative dementia, in vascular dementia or in a mixed form of
both) manifested as decline
in memory and intellectual capacity, vertigo, tinnitus, indisposition,
headache and sleep
disorders, general malaise;
-
in initial disturbances of blood perfusion of the extremities,
manifested as cold feet, tingling,
numbness or pain on walking.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
DISTURBANCES OF CEREBRAL CIRCULATION AND FUNCTION (SYNDROME OF
DEMENTIA IN PRIMARY
DEGENERATIVE DEMENTIA, IN VASCULAR DEMENTIA OR IN A MIXED FORM OF
BOTH):
The recommended dose is 1 capsule twice daily, in the morning and in
the evening.
INITIAL DISTURBANCES OF BLOOD PERFUSION OF THE EXTREMITIES:
The recommended dose is 1 capsule once daily, preferable in the
morning.
The capsules should be swallowed whole with some liquid. They may be
taken without regard to
meals. Concomitant intake of alcoholic beverages is not advised.
The first signs of improvement are usually observed after one month.
For a longer-lasting